These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
30. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]
31. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735 [TBL] [Abstract][Full Text] [Related]
32. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology. Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A Cells; 2021 Sep; 10(9):. PubMed ID: 34572052 [TBL] [Abstract][Full Text] [Related]
33. Inducible Alpha-Synuclein Expression Affects Human Neural Stem Cells' Behavior. Zasso J; Ahmed M; Cutarelli A; Conti L Stem Cells Dev; 2018 Jul; 27(14):985-994. PubMed ID: 29669468 [TBL] [Abstract][Full Text] [Related]
34. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466 [TBL] [Abstract][Full Text] [Related]
35. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease. Xun Z; Sowell RA; Kaufman TC; Clemmer DE Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766 [TBL] [Abstract][Full Text] [Related]
36. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431 [TBL] [Abstract][Full Text] [Related]
37. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus. Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589 [TBL] [Abstract][Full Text] [Related]
39. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage. Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963 [TBL] [Abstract][Full Text] [Related]
40. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]